Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gaush Meditech Ltd. ( (HK:2407) ) has shared an announcement.
Gaush Meditech Ltd announced that its subsidiary, Gaush Tech Ltd, has obtained a medical device registration certificate in China for its disposable ultrasonic emulsification vitrectomy irrigation-aspiration tubing kit. This product is crucial for ophthalmic surgeries like phacoemulsification and vitrectomy, offering advanced features such as dual-pump multi-power modes and continuous fluid level monitoring, which enhance surgical precision and fluidic stability. The approval is significant given the rising prevalence of fundus diseases in China, positioning Gaush Meditech as a key player in addressing these growing medical needs.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd is a company incorporated in the Cayman Islands, operating in the medical technology industry. The company, along with its subsidiaries, focuses on developing and providing medical devices, particularly in the field of ophthalmology.
Average Trading Volume: 130,263
Technical Sentiment Signal: Sell
Current Market Cap: HK$983.5M
For a thorough assessment of 2407 stock, go to TipRanks’ Stock Analysis page.